Enhanced Inactivated Poliovirus Vaccine

Enhanced Inactivated Poliovirus Vaccine

Saved in:

Bibliographic Details
Main Author:	Ronald Gold
Format:	Article
Language:	English
Published:	Wiley 1994-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1994/153783
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study
by: Kunal Kumar, et al.
Published: (2024-03-01)

Advancing poliovirus eradication: lessons learned from piloting direct molecular detection of polioviruses in high-risk and priority geographies
by: Paula L. Marcet, et al.
Published: (2025-02-01)

Development of RT-PCR Assays for Simple Detection and Identification of Sabin Virus Contaminants in the Novel Oral Poliovirus Vaccines
by: Olga Singh, et al.
Published: (2025-01-01)

Navigating the poliovirus threat: a call for training and resources in Gaza
by: Marwa Saleh, et al.
Published: (2025-01-01)

Inactivation of foot and mouth disease virus for vaccine production
by: D. V. Mikhalishin, et al.
Published: (2023-06-01)

Non-lytic spread of poliovirus requires the nonstructural protein 3CD
by: David Aponte-Diaz, et al.
Published: (2025-01-01)

Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020–2021): a cross-sectional studyResearch in context
by: Ali Faisal Saleem, et al.
Published: (2025-02-01)

Improvement of inactivated vaccine against porcine reproductive respiratory syndrome
by: D. A. Biruchenkov, et al.
Published: (2018-04-01)

Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
by: Shi-Hsia Hwa, et al.
Published: (2013-11-01)

What do Parents Learn by Reading a DPT Vaccine Information Form?
by: Ronald Gold, et al.
Published: (1994-01-01)

Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine
by: Mohamed Samy Abousenna, et al.
Published: (2025-02-01)

Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study
by: Abhishek Abhishek, et al.
Published: (2024-05-01)

ASSESSMENT OF EFFICACY AND SAFETY OF INACTIVATED RABIES VACCINES BASED ON “ARRIAH” STRAIN AND FORMULATED WITH DIFFERENT ADJUVANTS IN CATTLE
by: A. N. Balashov, et al.
Published: (2019-12-01)

Inactivation of Different Salmonella enteriditis Phage Types and Safety and Efficacy of Inactivated Products in Chicken
by: A. Akhtar, et al.
Published: (2021-01-01)

Activated Charcoal for Pesticide Inactivation
by: Frederick M. Fishel
Published: (2008-07-01)

Activated Charcoal for Pesticide Inactivation
by: Frederick M. Fishel
Published: (2008-07-01)

Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
by: Zhifei Chen, et al.
Published: (2025-01-01)

Characterization of the Immune Response Induced by a Commercially Available Inactivated Bluetongue Virus Serotype 1 Vaccine in Sheep
by: Ana Cristina Pérez de Diego, et al.
Published: (2012-01-01)

Molecular characterization of avian pathogenic Escherichia coli strains in Jiangxi Province, China, and development of polyvalent inactivated vaccines
by: Jia Tan, et al.
Published: (2025-02-01)

Effect of 1-(phenyl)-N’-(4-methoxybenzylidene)-9H-pyrido[3,4-b] indole-3-carbohydrazide on in vitro poliovirus replication
by: Santos Patricia Regina, et al.
Published: (2015-03-01)

X-Chromosome Inactivation and Related Diseases
by: Zhuo Sun, et al.
Published: (2022-01-01)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
by: Cucunawangsih Cucunawangsih, et al.
Published: (2021-01-01)

Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine
by: Guanguan Qiu, et al.
Published: (2025-01-01)

A therapy inactivating the tumor angiogenic factors
by: Cristian Morales-Rodrigo
Published: (2012-11-01)

Conditional Inactivation of HIF-1 Using Intrabodies
by: Arjan J. Groot, et al.
Published: (2008-01-01)

Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin
by: Cory R. Hewitt, et al.
Published: (2025-01-01)

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants
by: A. N. Balashov, et al.
Published: (2020-03-01)

SPECIFIC ASPECTS OF AVIBACTERIUM PARAGALLINARUM INACTIVATION WITH FORMALDEHYDE AND THIOMERSAL
by: M. S. Firsova, et al.
Published: (2019-10-01)

Optimization of RHDV type 1 and 2 inactivation modes
by: E. D. Kunikova, et al.
Published: (2021-03-01)

N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan-Aluminum Nano-Adjuvant Elicit Strong Immune Responses in Porcine Epidemic Diarrhea Inactivated Vaccine
by: Jin Z, et al.
Published: (2025-01-01)

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza in elderly Chinese patients with diabetes: A test-negative design case-control study
by: Zhengyan Chen, et al.
Published: (2025-12-01)

Correction: Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
by: Jihane Belayachi, et al.
Published: (2024-01-01)

Unilateral Anterior Scleritis Following the Booster Shot of Inactivated COVID-19 (Sinopharm) Vaccine in a 52-Year-Old Woman: A Case Report
by: Kimia Jazi, et al.
Published: (2024-01-01)

Correction: Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
Published: (2024-01-01)

Beyond Erythromycin ...
by: Ronald Gold
Published: (1994-01-01)

Pasteurisation temperatures effectively inactivate influenza A viruses in milk
by: Jenna Schafers, et al.
Published: (2025-01-01)

Antimicrobial photodynamic inactivation of Pseudomonas aeruginosa persister cells and biofilms
by: Mona Mahmoud, et al.
Published: (2025-02-01)

Pseudomonas cepacia in cystic fibrosis
by: Ronald Gold
Published: (1993-01-01)

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters
by: Ryuta Uraki, et al.
Published: (2025-02-01)

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
by: Shuaibing Dong, et al.
Published: (2024-12-01)